Head of Product Growth (Referrals & Viral Loops) at AIOS — Remote, $200k-$400k/yr + 0.15%-0.50%

Benefits

Parental leave

Not verified

Non-birth-parent leave

Not verified

Family-building benefits

• Fertility benefits: Not verified
• Adoption assistance: Not verified
• Surrogacy assistance: Not verified

Mental health support

Not verified

Relocation assistance

Not verified

Childcare support

Not verified

Learning budget

Not verified

Verification

Not verified

Salary

$200K-$400K From the posting source checked Jun 20, 2026

Was this benefit information wrong? Tell us.

Market context

U.S. role benchmark (BLS OEWS)

$102,662 U.S. median for this role

Projected growth (BLS Employment Projections)

+5.4% - Faster than average

U.S. benchmark only; posted salary is not compared across countries or currencies.

Matched to SOC 11-1021 - Product Management aggregate by role bucket.

Source: U.S. Bureau of Labor Statistics, OEWS, May 2024 and Employment Projections, 2024-2034.

Role

Role function

Product From the posting source checked Jun 20, 2026

Seniority

Senior From the posting source checked Jun 20, 2026

Work mode

Remote From the posting source checked Jun 20, 2026

In-office days

0 days From the posting source checked Jun 20, 2026

Schedule

Shift type

Not verified

Weekend work

Not verified

Company

Company stage

Seed From the posting source checked Jun 20, 2026

Application

Cover letter

Not verified

Assessment

Not verified

Deadline

Not stated

Where they hire

State eligibility is not yet verified.

About this role

Head of Product Growth (Referrals & Viral Loops) at AIOS — Remote, $200k-$400k/yr + 0.15%-0.50% Remote (US or European timezones) | Remote | UK | India | Berlin | Israel | Canada | France | Netherlands | Singapore | Sweden | US ABOUT AIOS AIOS is building the first vertically integrated AI doctor in Europe. We're at >$250M ARR, serving >100k/mo patients, growing >10x YoY. We're Europe's fastest growing healthcare company. We're profitable. As our wedge into the European healthcare system we're using GLP-1s, the fastest growing consumer product in history. We're the only AI-native GLP-1 provider in Europe. Our master plan: - Step 1 → $1Bn/yr: Over the last 12 months we've grown 40x to >100k UK GLP-1 patients. In 2026, we'll hit $1Bn/yr and become #1 GLP-1 provider in UK. - Step 2 → $10Bn/yr: Blitzscale Europe. Become Europe's largest GLP-1 provider by acquiring, retooling, then rapidly scaling regulated infrastructure across the top 10 EU markets, just as we did in the UK. - Step 3 → $100Bn/yr: Use our scale to vertically integrate across agentic patient care, autonomous prescribing, robotic dispensing, and dark factory manufacturing of medication. We'll be the first and only vertically integrated AI doctor in Europe. TLDR = 2026-2030 is the blitzscale landgrab until the semaglutide patent cliff, then we vertically integrate and own the whole value chain. The only way to keep up with this scale is to replace all marginal human time with AI. Our infrastructure will have served 100 million patients

Read the full description at jobs.ashbyhq.com. FewerJobs shows a preview and links to the original posting.